|
CA672478A
(en)
|
|
1963-10-15 |
Heim Roger |
Psilocybin and psilocin
|
|
GB911946A
(en)
|
1958-02-21 |
1962-12-05 |
Sandoz Ltd |
Psilocybin and psilocin and processes for their preparation
|
|
LU36879A1
(fr)
|
1958-02-21 |
|
|
|
|
BE582353A
(fr)
|
1958-09-12 |
|
|
|
|
US3075992A
(en)
|
1958-09-12 |
1963-01-29 |
Sandoz Ltd |
Esters of indoles
|
|
US3192111A
(en)
|
1959-02-16 |
1965-06-29 |
Sandoz Ltd |
Method of inducing therapeutic tranquilization with psilocybin and psilocin
|
|
IE24138L
(en)
|
1959-02-18 |
1959-08-21 |
Sandoz Ag |
Psilocybin and psilocin
|
|
JPS5576859A
(en)
|
1978-12-01 |
1980-06-10 |
Fujimoto Seiyaku Kk |
Novel preparation of 4-hydroxyindole
|
|
JPS5728046A
(en)
|
1980-07-28 |
1982-02-15 |
Nissan Chem Ind Ltd |
Preparation of 4-substituted indole
|
|
US4499096A
(en)
|
1983-11-18 |
1985-02-12 |
Lotsof Howard S |
Rapid method for interrupting the narcotic addiction syndrome
|
|
EP0152379A3
(fr)
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Procédé pour la préparation de compositions pharmaceutiques contenant des liposomes unilamellaires
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
IL76591A0
(en)
|
1984-10-05 |
1986-02-28 |
Bioferon Biochem Substanz |
Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
|
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
US4587243A
(en)
|
1985-07-15 |
1986-05-06 |
Lotsof Howard S |
Rapid method for interrupting the cocaine and amphetamine abuse syndrome
|
|
DE218479T1
(de)
|
1985-10-04 |
1992-03-19 |
South African Inventions Development Corp., Pretoria, Transvaal |
Reagens und verfahren.
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
DE68928415T2
(de)
|
1989-09-05 |
1998-02-26 |
Univ Utah Research Inst |
Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US5935925A
(en)
|
1990-05-08 |
1999-08-10 |
Synaptic Pharmaceutical Corporation |
Methods of treating migraine and compounds useful for such methods
|
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
ES2193132T3
(es)
|
1990-10-19 |
2003-11-01 |
Univ New York |
Procedimiento para transplantar celulas en el cerebro y utilizaciones terapeuticas del mismo.
|
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
|
FR2675504B1
(fr)
|
1991-04-16 |
1995-01-27 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
|
|
US5468486A
(en)
|
1992-01-21 |
1995-11-21 |
The University Of Tennessee Research Corporation |
Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
|
|
EP0566135A1
(fr)
|
1992-04-17 |
1993-10-20 |
Takeda Chemical Industries, Ltd. |
Composition transmucosale contenant un peptide et un dérivé de la cytidine
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
TW252979B
(fr)
|
1992-12-24 |
1995-08-01 |
Erba Carlo Spa |
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US20060019963A1
(en)
|
1994-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Compounds
|
|
DK0804200T3
(da)
|
1994-07-25 |
2006-09-11 |
Nda Int Inc |
Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr
|
|
US5874477A
(en)
|
1994-08-12 |
1999-02-23 |
The University Of Hawaii |
Method of treatment for malaria utilizing serotonin receptor ligands
|
|
US5696125A
(en)
|
1995-02-24 |
1997-12-09 |
Research Foundation Of The State University Of New York |
Substance abuse-induced hemorrhagic stoke in an animal model
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
CA2195119C
(fr)
|
1995-06-09 |
2001-09-11 |
Mark Chasin |
Procedes et compositions d'anesthesie locale prolongee
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
DE19542281C2
(de)
|
1995-11-14 |
1997-12-04 |
Boehringer Ingelheim Kg |
Verwendung von Epinastin für die Behandlung der Migräne
|
|
FR2744361B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744364B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744363B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744362B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
WO1997035584A1
(fr)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Procede de traitement de la douleur
|
|
TW448171B
(en)
|
1996-06-06 |
2001-08-01 |
Yamanouchi Pharma Co Ltd |
Imidazole-substituted quinoxalinedione derivatives
|
|
AU3290397A
(en)
|
1996-06-10 |
1998-01-07 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5902815A
(en)
|
1996-09-03 |
1999-05-11 |
Washington University |
Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
|
|
US5958919A
(en)
|
1996-09-20 |
1999-09-28 |
Washington University |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
|
|
US5891885A
(en)
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US5804592A
(en)
|
1997-05-30 |
1998-09-08 |
Unimed Pharmaceuticals, Inc. |
Method for improving disturbed behavior and elevating mood in humans
|
|
IL132784A
(en)
|
1997-05-07 |
2004-07-25 |
Unimed Pharmaceutical Inc |
Pharmaceutical compositions containing dronabinol
|
|
WO1998059234A1
(fr)
|
1997-06-24 |
1998-12-30 |
The University Of Wyoming |
Procede et appareil de detection d'une substance a consommation reglementee
|
|
GB9715082D0
(en)
|
1997-07-17 |
1997-09-24 |
Scherer Ltd R P |
Treatment of attention deficit hyperactivity disorder and narcolepsy
|
|
US20010004644A1
(en)
|
1997-07-21 |
2001-06-21 |
Levin Bruce H. |
Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
|
|
US7799337B2
(en)
|
1997-07-21 |
2010-09-21 |
Levin Bruce H |
Method for directed intranasal administration of a composition
|
|
WO1999009828A1
(fr)
|
1997-08-25 |
1999-03-04 |
Pentech Pharmaceuticals, Inc. |
Traitement de la phobie sociale
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
AU754088B2
(en)
|
1997-09-04 |
2002-11-07 |
Demerx, Inc. |
Noribogaine in the treatment of pain and drug addiction
|
|
DE19738855C2
(de)
|
1997-09-05 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
WO1999021562A1
(fr)
|
1997-10-28 |
1999-05-06 |
Asivi, Llc |
Traitement du dysfonctionnement sexuel chez la femme
|
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
ITTO980264A1
(it)
|
1998-03-26 |
1999-09-26 |
Silvio Rossi |
Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
|
|
JP2002518435A
(ja)
|
1998-06-22 |
2002-06-25 |
クイーンズ ユニバーシティ アット キングストン |
女性の性機能不全の治療または改善のための方法および組成物
|
|
WO2000003746A2
(fr)
|
1998-07-14 |
2000-01-27 |
The Brigham And Women's Hospital, Inc. |
Remise a niveau de la synthase dl'oxyde nitrique des cellules endotheliales de type iii par des agents venant disloquer l'organisation cytosquelettique de l'actine
|
|
WO2000003679A2
(fr)
|
1998-07-14 |
2000-01-27 |
Adams Food Ltd. |
Composition nutritivement active pour durcir les ongles
|
|
EP1096927A4
(fr)
|
1998-07-16 |
2002-09-04 |
Massachusetts Inst Technology |
Composition pour le traitement du stress
|
|
WO2000006139A2
(fr)
|
1998-07-31 |
2000-02-10 |
Vela Pharmaceuticals Inc. |
Procedes et compositions pour le traitement et la prevention des toxicomanies a l'aide de moclobemide
|
|
BR9913800A
(pt)
|
1998-09-18 |
2001-05-29 |
Alcon Lab Inc |
Método para tratar glaucoma, e, composição para tratar glaucoma
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
PT1146862E
(pt)
|
1999-01-29 |
2003-09-30 |
Disphar Int Bv |
Composicoes farmaceuticas
|
|
DK1158973T3
(da)
|
1999-02-24 |
2005-05-30 |
Univ Cincinnati |
Anvendelse af sulfamatderivater til behandling af impulskontrolafvigelser
|
|
AU3760300A
(en)
|
1999-03-19 |
2000-10-09 |
Brigham And Women's Hospital |
Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
|
|
US6340476B1
(en)
|
1999-04-06 |
2002-01-22 |
Armaquest, Inc. |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
KR20010104388A
(ko)
|
1999-04-07 |
2001-11-24 |
데이비드 존 우드 |
복합요법에서의 ｃｙｐ2ｄ6 억제제의 용도
|
|
US6126924A
(en)
|
1999-05-27 |
2000-10-03 |
Scales-Medeiros; Virginia A. |
Light responsive self-tanning products and methods for use
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
US6489341B1
(en)
|
1999-06-02 |
2002-12-03 |
Sepracor Inc. |
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
MXPA02001882A
(es)
|
1999-08-23 |
2002-08-20 |
Univ Tulane |
Modulacion del transportador de leptina a traves de la barrera hemato-encefalica.
|
|
US6204245B1
(en)
|
1999-09-17 |
2001-03-20 |
The Regents Of The University Of California |
Treatment of narcolepsy with immunosuppressants
|
|
AU8003800A
(en)
|
1999-10-08 |
2001-04-23 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
ES2162746B1
(es)
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
|
MXPA02007039A
(es)
|
2000-01-18 |
2003-09-25 |
Univ Pennsylvania |
Crecimiento ocular y antagonistas nicotinicos.
|
|
US20030096831A1
(en)
|
2000-01-18 |
2003-05-22 |
Stone Richard A. |
Ocular growth and nicotinic antagonists
|
|
FR2804603B1
(fr)
|
2000-02-04 |
2004-01-23 |
Rhodia Chimie Sa |
Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
AU2001243369A1
(en)
|
2000-03-14 |
2001-09-24 |
Massachusetts Institute Of Technology |
Composition and method to treat weight gain and obesity attributable to psychotropic drugs
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
AU2001247767A1
(en)
|
2000-03-27 |
2001-10-08 |
Pe Corporation (Ny) |
Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
|
|
US6380176B2
(en)
|
2000-03-28 |
2002-04-30 |
Ajinomoto Co., Inc. |
Method for inhibiting non-intentional behavior with a running neuron inhibitory substance
|
|
DE10018834A1
(de)
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
|
AU6106801A
(en)
|
2000-04-28 |
2001-11-12 |
Gary W. Neal |
Trans-clitoral administration of therapy
|
|
DE60133270T2
(de)
|
2000-05-10 |
2009-04-23 |
Jagotec Ag |
Zerkleinerung mittels mahlkörper
|
|
US20070059367A1
(en)
|
2000-06-06 |
2007-03-15 |
Cherukuri S R |
Drug Delivery System and Associated Methods
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
EP1476171B1
(fr)
|
2000-07-19 |
2010-09-08 |
North-West University |
Transport de substances d'acides nucleiques
|
|
AU2001291114A1
(en)
|
2000-09-19 |
2002-04-02 |
Microbia, Inc. |
Modulation of secondary metabolite production by zinc binuclear cluster proteins
|
|
US9399050B2
(en)
|
2000-10-04 |
2016-07-26 |
Paul Edward Stamets |
Controlling insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
|
|
US9474776B2
(en)
|
2000-10-04 |
2016-10-25 |
Paul Edward Stamets |
Integrative fungal solutions for protecting bees
|
|
US20030119884A1
(en)
|
2000-11-01 |
2003-06-26 |
Epstein Mel H. |
Methods and compositions for regulating memory consolidation
|
|
US20070100000A1
(en)
|
2000-11-01 |
2007-05-03 |
Epstein Mel H |
Methods of providing neuroprotection
|
|
CA2359812C
(fr)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
|
|
AR031473A1
(es)
|
2000-11-20 |
2003-09-24 |
Lundbeck & Co As H |
Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
|
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
|
IL139975A0
(en)
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
MXPA03004871A
(es)
|
2000-11-30 |
2003-08-19 |
Pfizer Prod Inc |
Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
|
|
DE60106968T2
(de)
|
2000-11-30 |
2005-11-03 |
Pfizer Products Inc., Groton |
Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
|
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
|
US20020137785A1
(en)
|
2001-03-26 |
2002-09-26 |
George Kindness |
Inflammatory mechanism modulator composition and methods with anti-asthmatic properties
|
|
US20050096396A1
(en)
|
2002-03-28 |
2005-05-05 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
JP4427253B2
(ja)
|
2001-03-30 |
2010-03-03 |
フイラデルフイア・ヘルス・アンド・エデユケーシヨン・コーポレーシヨン |
免疫調節およびセロトニンファミリー受容体に関する細胞プロセスに対する影響
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
US20040132780A1
(en)
|
2001-05-04 |
2004-07-08 |
Allen Christopher P. |
Method and compositions for treating migraines
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
US20040023952A1
(en)
|
2001-06-20 |
2004-02-05 |
Leventhal Audie G. |
Enhanced brain function by gaba-ergic stimulation
|
|
AU2002332942A1
(en)
|
2001-08-20 |
2003-03-03 |
Greiner Bio-One Gmbh |
Device and method for determining an analyte
|
|
US6541043B2
(en)
|
2001-08-28 |
2003-04-01 |
Dexgen Pharmaceuticals, Inc. |
Method and synergistic composition for treating attention deficit/hyperactivity disorder
|
|
US20030099711A1
(en)
|
2001-08-29 |
2003-05-29 |
David Meadows |
Sustained release preparations
|
|
AU2002347404A1
(en)
|
2001-09-14 |
2003-04-01 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
WO2003026564A2
(fr)
|
2001-09-27 |
2003-04-03 |
Pharmacia Ab |
Composition pharmaceutique
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
US20060264508A1
(en)
|
2001-10-16 |
2006-11-23 |
Stone Richard A |
Modulation of ocular growth and myopia by gaba drugs
|
|
US20030082225A1
(en)
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
AU2002340439A1
(en)
|
2001-11-09 |
2003-05-26 |
Chiron Corporation |
Method of vaccinating a human patient to prevent metastatic tumors
|
|
GB0127832D0
(en)
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
|
JP2005519876A
(ja)
|
2001-11-27 |
2005-07-07 |
メルク エンド カムパニー インコーポレーテッド |
２−アミノキノリン化合物
|
|
WO2003045920A1
(fr)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
Composes 4-aminoquinoleines
|
|
EP1509204A4
(fr)
|
2001-11-29 |
2005-07-13 |
Rettenmaier & Soehne Gmbh & Co |
Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee
|
|
US20030171435A1
(en)
|
2002-01-23 |
2003-09-11 |
Drug Abuse Sciences, Inc. |
New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
|
|
US7241797B2
(en)
|
2002-01-23 |
2007-07-10 |
University Of Cincinnati |
Method of increasing milk production
|
|
CN1267087C
(zh)
|
2002-02-07 |
2006-08-02 |
法马西亚公司 |
药物片剂
|
|
RU2285520C2
(ru)
|
2002-02-07 |
2006-10-20 |
Фармация Корпорейшн |
Фармацевтическая дозированная форма для доставки через слизистую оболочку
|
|
US20030153552A1
(en)
|
2002-02-14 |
2003-08-14 |
Mash Deborah C. |
Method of treating chemical dependency in mammals and a composition therefor
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
|
US20030199439A1
(en)
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
|
EP1499309A4
(fr)
|
2002-04-24 |
2008-05-28 |
Cypress Bioscience Inc |
Prevention et traitement de troubles somatiques fonctionnels, y-compris les troubles lies au stress
|
|
WO2003092676A1
(fr)
|
2002-04-29 |
2003-11-13 |
The General Hospital Corporation |
Compositions et methodes de prevention de l'abus de medicaments administres par voie orale
|
|
AUPS317102A0
(en)
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
|
JP2005537244A
(ja)
|
2002-06-28 |
2005-12-08 |
ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド |
療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
|
|
US20040006043A1
(en)
|
2002-07-02 |
2004-01-08 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
|
|
US10738268B2
(en)
|
2016-08-21 |
2020-08-11 |
Insectergy, Llc |
Cannabis nanoemulsion methods
|
|
US20050148673A1
(en)
|
2002-07-11 |
2005-07-07 |
Harbut Ronald E. |
Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
|
|
AU2003246690B2
(en)
|
2002-07-17 |
2010-03-11 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
AU2003252318A1
(en)
|
2002-08-09 |
2004-02-25 |
Mitsubishi Pharma Corporation |
Regulator for mental disease risk fragility
|
|
US20030114512A1
(en)
|
2002-09-09 |
2003-06-19 |
Collier Robert J |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
AU2003278832A1
(en)
|
2002-09-13 |
2004-04-30 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
|
AU2003267241A1
(en)
|
2002-09-19 |
2004-04-08 |
Merck And Co., Inc. |
Method for treating depression and/or anxiety
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
DE10244504A1
(de)
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
|
MXPA05003744A
(es)
|
2002-10-11 |
2005-09-20 |
Idea Ag |
Agregado de deformabilidad aumentada, que comprende al menos tres anfipatos, para un transporte mejorado a traves de barreras semi-permeables y para la aplicacion de farmacos no invasivos en vivo, en especial a traves de la piel.
|
|
US7132122B2
(en)
|
2002-10-30 |
2006-11-07 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using UV light and selected uses thereof
|
|
DE10250944B9
(de)
|
2002-10-31 |
2004-09-16 |
Cell Center Cologne Gmbh |
Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
BR0317747A
(pt)
|
2002-12-24 |
2005-11-22 |
Neurochem Int Ltd |
Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
|
|
US7601740B2
(en)
|
2003-01-16 |
2009-10-13 |
Acadia Pharmaceuticals, Inc. |
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
|
|
BRPI0406592A
(pt)
|
2003-01-23 |
2005-12-20 |
Acadia Pharm Inc |
Usos de n-desmetilclozapina, métodos para o tratamento de psicose, de distúrbios afetivos, de demência, de dor neuropática e de glaucoma e composição farmacêutica
|
|
US20040186155A1
(en)
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
|
EP1603548A4
(fr)
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
Composition et methode de traitement de troubles neurodegeneratifs
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
CA2519117C
(fr)
|
2003-03-17 |
2010-03-02 |
Neurohealing Pharmaceuticals, Inc. |
Traitement dopaminergique tres puissant de deficiences neurologiques associees a des lesions du cerveau
|
|
US7517520B2
(en)
|
2003-03-26 |
2009-04-14 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
JP4898445B2
(ja)
|
2003-05-29 |
2012-03-14 |
シャイア エルエルシー |
乱用抵抗性アンフェタミン化合物類
|
|
CA2528032A1
(fr)
|
2003-06-03 |
2004-12-16 |
Beth Israel Deaconess Medical Center |
Methodes et composes pour le traitement de la stenose vasculaire
|
|
US20070065463A1
(en)
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
|
JP4174016B2
(ja)
|
2003-07-11 |
2008-10-29 |
株式会社ビーエル |
競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット
|
|
WO2005007111A2
(fr)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Derives de tetrahydroquinoleine constituant des modulateurs des recepteurs des cannabinoides
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US20050203011A1
(en)
|
2003-09-19 |
2005-09-15 |
The Regents Of The University Of California |
Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
|
|
US20050070501A1
(en)
|
2003-09-29 |
2005-03-31 |
New York Blood Center, Inc. |
Water dispersible film
|
|
EP1670444B1
(fr)
|
2003-10-03 |
2011-04-27 |
Veijlen N.V. |
Utilisation de composes pouvant accroitre le niveau serique d'igf-1 pour preparation d'une composition therapeutique destinee au traitement de divers etats pathologiques
|
|
WO2005037199A2
(fr)
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Derives de pyrazole utilises comme modulateurs du recepteur de cannabinoide
|
|
CA2585024A1
(fr)
|
2003-10-24 |
2005-05-06 |
Azopax Therapeutics Llc |
Compositions a base de macromeres fondus
|
|
US20070053954A1
(en)
|
2003-10-24 |
2007-03-08 |
Rowe Stephen C |
Macromer-melt formulations
|
|
JP2005132747A
(ja)
|
2003-10-29 |
2005-05-26 |
Ajinomoto Co Inc |
老齢伴侶動物の老化行動改善剤
|
|
CN1917876A
(zh)
|
2003-12-16 |
2007-02-21 |
Cns生物有限公司 |
方法和组合物
|
|
US20050260258A1
(en)
|
2003-12-18 |
2005-11-24 |
The Texas A&M University System |
Use of vitelline protein B as a microencapsulating additive
|
|
WO2005063248A1
(fr)
|
2003-12-22 |
2005-07-14 |
Sepracor Inc. |
Therapie combinatoire avec la modafinile pour ameliorer la qualite du sommeil
|
|
CA2549638A1
(fr)
|
2003-12-23 |
2005-07-14 |
Pfizer Products Inc. |
Combinaison therapeutique d'amelioration neuro-cognitive et de traitement de troubles psychotiques
|
|
GB0400802D0
(en)
|
2004-01-14 |
2004-02-18 |
Daniolabs Ltd |
Compounds for the treatment of disease
|
|
AU2005209310B2
(en)
|
2004-01-29 |
2011-01-06 |
Neuromolecular, Inc. |
Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system-related conditions
|
|
CA2556216A1
(fr)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Methodes et compositions de traitement de troubles psychiatriques
|
|
WO2005079773A2
(fr)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Methodes et compositions destinees au traitement de l'epilepsie, des troubles epileptiques et d'autres troubles du systeme nerveux central
|
|
WO2005082277A1
(fr)
|
2004-02-18 |
2005-09-09 |
Stanford University |
Systemes d'administration de medicaments utilisant des films d'oxyde mesoporeux
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
FR2867075B1
(fr)
|
2004-03-03 |
2006-07-14 |
Ethypharm Sa |
Procede de preparation de microspheres biodegradables calibrees
|
|
AU2005222640A1
(en)
|
2004-03-12 |
2005-09-29 |
The Mclean Hospital Corporation |
Salvinorin derivatives and uses thereof
|
|
US20060270592A1
(en)
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
|
EP1737473A4
(fr)
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
Combinaisons de lithium et utilisations associees
|
|
WO2005102390A2
(fr)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinaisons comprenant des ligands alpha-2-delta et des antagonistes des recepteurs de nmda
|
|
RU2253461C1
(ru)
|
2004-04-30 |
2005-06-10 |
Общество с ограниченной ответственностью "Паркинфарм" |
Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
|
|
US20050255091A1
(en)
|
2004-05-14 |
2005-11-17 |
Loomis Gary L |
Hydrogels for biomedical applications
|
|
US20050261278A1
(en)
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050265955A1
(en)
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
NL1026634C2
(nl)
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
|
US7799802B2
(en)
|
2004-08-03 |
2010-09-21 |
Institstute of Oriental Medical Science Inc. |
Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
|
|
US20060030625A1
(en)
|
2004-08-06 |
2006-02-09 |
Cheryle Ram Hart |
Dietary neurotransmitter precursors for balanced synthesis of neurotransmitters
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
DK1804836T3
(da)
|
2004-09-24 |
2011-01-24 |
Beth Israel Hospital |
Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
|
|
EP1799640A4
(fr)
|
2004-09-27 |
2009-09-02 |
Organix Inc |
Composes indole convenant comme agents selectifs par rapport a la serotonine
|
|
EP1799264A2
(fr)
|
2004-10-08 |
2007-06-27 |
Neuromolecular Pharmaceuticals Inc |
Methodes et compositions de traitement de la douleur de migraine
|
|
WO2006053383A1
(fr)
|
2004-11-22 |
2006-05-26 |
Anadis Ltd |
Préparations bioactives
|
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
|
US7294649B2
(en)
|
2004-12-17 |
2007-11-13 |
Roche Diagnostics Operatins, Inc. |
Methamphetamine derivatives and conjugates for immunoassay
|
|
AU2005319367B2
(en)
|
2004-12-20 |
2012-05-24 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical compositions for sleep disorders
|
|
EP1844189B1
(fr)
|
2005-01-10 |
2020-10-28 |
Smiths Detection Inc. |
Procédé de préparation d'un écouvillon d'échantillonnage
|
|
DE102005004343A1
(de)
|
2005-01-25 |
2006-08-10 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Behandlung von Phantomphänomenen
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
WO2006102157A1
(fr)
|
2005-03-21 |
2006-09-28 |
Ivax Pharmaceuticals S.R.O. |
Inhibiteur de cristallisation et son utilisation dans des capsules de gelatine
|
|
US20090232898A1
(en)
|
2005-03-28 |
2009-09-17 |
Anders Pettersson |
Pharmaceutical Compositions Useful in the Treatment of Migraine
|
|
US20060229293A1
(en)
|
2005-04-06 |
2006-10-12 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C
|
|
EP1865980A4
(fr)
|
2005-04-08 |
2009-11-11 |
Shire Llc |
Promedicaments a base d'amphetamine resistants a la consommation abusive
|
|
WO2007004067A2
(fr)
|
2005-04-15 |
2007-01-11 |
Interface Biologics Inc. |
Procedes et compositions permettant d'administrer des agents biologiquement actifs
|
|
WO2006113602A2
(fr)
|
2005-04-15 |
2006-10-26 |
Board Of Trustees Of Michigan State University |
Peptides liant l'ascorbate
|
|
CN101218223A
(zh)
|
2005-04-22 |
2008-07-09 |
惠氏公司 |
苯并二烷和苯并二氧戊环衍生物及其应用
|
|
EP1877382B1
(fr)
|
2005-05-06 |
2012-11-28 |
Smiths Detection Inc. |
Utilisation de isobutyramide comme un réactif d'ionisation en spectrométrie de mobilité ionique
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
|
JP5284779B2
(ja)
|
2005-06-07 |
2013-09-11 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
コンジュゲート化された向精神薬の新規な塩およびその調製方法
|
|
CA2612309C
(fr)
|
2005-06-16 |
2014-12-16 |
Mohammed Saeed |
Composition et procede d'inhibition, de prevention ou d'amelioration des complications associees a l'ingestion d'une substance ou d'un agent medicinal, chimique ou biologique
|
|
US7645802B2
(en)
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
WO2007052289A2
(fr)
|
2005-07-22 |
2007-05-10 |
Rubicon Research Pvt Ltd. |
Nouvelle composition de comprime dispersible
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
|
DE102005055866A1
(de)
|
2005-11-23 |
2007-05-24 |
Hte Ag The High Throughput Experimentation Company |
Verfahren zur Herstellung von Aryl-Aryl gekoppelter Verbindungen
|
|
SG169334A1
(en)
|
2006-01-21 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Dosage form and method for the delivery of drugs of abuse
|
|
JP2009525124A
(ja)
|
2006-02-02 |
2009-07-09 |
メドロジックス・ディバイス・コーポレーション |
ゾル−ゲル組成物を含む生物活性材料送達系
|
|
US20070203216A1
(en)
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
US20070190130A1
(en)
|
2006-02-16 |
2007-08-16 |
Mark William A |
Protein hydrolysate excipients
|
|
US20080075789A1
(en)
|
2006-02-28 |
2008-03-27 |
The Regents Of The University Of California |
Genes differentially expressed in bipolar disorder and/or schizophrenia
|
|
MX2008011236A
(es)
|
2006-03-01 |
2009-02-10 |
Tristrata Inc |
Composicion y metodo para tratamiento topico de trastornos dermatologicos que responden a alquitran.
|
|
FR2898271B1
(fr)
|
2006-03-09 |
2009-01-16 |
Pierre Fabre Medicament Sa |
Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
|
|
EP2012762A4
(fr)
|
2006-03-22 |
2010-03-10 |
Sinai School Medicine |
Administration intra-nasale de ketamine pour traiter la depression
|
|
WO2006079999A2
(fr)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction d'un nouvel etat psychique a l'aide d'un agoniste de 5-ht2a et d'un antagoniste de nmda
|
|
JP2009533519A
(ja)
|
2006-04-14 |
2009-09-17 |
インターフェース バイオロジクス，インコーポレーテッド |
グラフトポリマーおよびその使用
|
|
GB0608647D0
(en)
|
2006-05-02 |
2006-06-14 |
Haritou Susan J A |
Methods of diagnosis and treatment
|
|
ES2529455T3
(es)
|
2006-05-12 |
2015-02-20 |
Shire Llc |
Sistema de administración de fármacos por dosis controladas
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
EP1948155B1
(fr)
|
2006-06-28 |
2012-03-07 |
Chelsea Therapeutics Inc. |
Compositions pharmaceutiques comprenant du droxidopa
|
|
EP2040758A4
(fr)
|
2006-06-30 |
2014-09-17 |
Interface Biologics Inc |
Polymeres biosensibles
|
|
AU2007274583B2
(en)
|
2006-07-17 |
2012-11-01 |
Bar-Ilan University |
Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
|
|
CA2692440A1
(fr)
|
2006-07-20 |
2008-01-24 |
Cascade Therapeutics Inc. |
Tetrahydro-5-pyrido[2,3-d]azepines comme ligands de 5-ht2c
|
|
US20080026189A1
(en)
|
2006-07-27 |
2008-01-31 |
Chun-Wei Lin |
Thin key structure for generating dazzling light
|
|
BRPI0715633A2
(pt)
|
2006-08-23 |
2013-07-02 |
Univ Montana |
mÉtodo de reduÇço de dano em cÉlula neuronal
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008026046A1
(fr)
|
2006-08-30 |
2008-03-06 |
Pfizer Products Inc. |
Antagonistes à base de morpholine de la dopamine d3
|
|
JP2010502623A
(ja)
|
2006-08-31 |
2010-01-28 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｎｏｇｏレセプターポリペプチドの末梢投与に関する方法
|
|
AU2007299920A1
(en)
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
WO2008039179A1
(fr)
|
2006-09-26 |
2008-04-03 |
Addiction Research Institute, Inc. |
Compositions de traitement de l'hépatite c et procédés d'utilisation des compositions de traitement de l'hépatite c
|
|
WO2008038291A1
(fr)
|
2006-09-27 |
2008-04-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combinaison de médicaments liposomiaux anti-cancer et d'agents augmentant le ph du système lysosome/endosome pour une thérapie
|
|
JP2010508279A
(ja)
|
2006-10-27 |
2010-03-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
破壊的行動障害の処置法
|
|
CA2667553A1
(fr)
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Procedes et combinaison de therapies pour le traitement de la maladie d'alzheimer
|
|
JP2010508354A
(ja)
|
2006-10-31 |
2010-03-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
広汎性発達障害の処置
|
|
US8653106B2
(en)
|
2010-07-30 |
2014-02-18 |
Pisgah Laboratories, Inc. |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
|
|
US20080293695A1
(en)
|
2007-05-22 |
2008-11-27 |
David William Bristol |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
|
|
US7718649B1
(en)
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
|
ES2364865T3
(es)
|
2006-12-11 |
2011-09-15 |
Kempharm, Inc. |
Conjugados de ornitina de la anfetamina y procedimientos de fabricación y de utilización de los mismos.
|
|
ES2302650B1
(es)
|
2007-01-11 |
2009-02-16 |
Tedec-Meiji Farma, S.A. |
Composicion de rapida desintegracion en la cavidad bucal.
|
|
US20100076006A1
(en)
|
2007-01-31 |
2010-03-25 |
University Of Virginia Patent Foundation |
Topiramate Plus Naltrexone for the Treatment of Addictive Disorders
|
|
JP2010518113A
(ja)
|
2007-02-08 |
2010-05-27 |
ケムファーム・インコーポレーテッド |
アンフェタミンおよび他の刺激薬の極性親水性プロドラッグ、およびそれらの製造方法および使用方法
|
|
NZ579368A
(en)
|
2007-03-09 |
2012-03-30 |
Chelsea Therapeutics Inc |
Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
|
|
EP2142185B1
(fr)
|
2007-03-12 |
2012-08-15 |
Chelsea Therapeutics, Inc. |
Droxidopa et composition pharmaceutique de celle-ci pour le traitement de l'hypotension véhiculée par voie neurale
|
|
WO2008115797A1
(fr)
|
2007-03-16 |
2008-09-25 |
Pavo, Inc. |
Compositions thérapeutiques et procédés associés
|
|
DE102007014286A1
(de)
|
2007-03-19 |
2008-09-25 |
Universität Tübingen |
Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
|
|
CN103418062B
(zh)
|
2007-03-30 |
2017-04-12 |
菲利普莫里斯生产公司 |
用于输送药剂的装置和方法
|
|
AT505086B1
(de)
|
2007-04-02 |
2009-06-15 |
Planta Naturstoffe Vertriebsge |
Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
|
|
WO2008122990A1
(fr)
|
2007-04-04 |
2008-10-16 |
Almet Corporation Limited |
Extracteur à courant ascendant et à compactage et procédé d'utilisation de ce dernier
|
|
US8747832B2
(en)
|
2007-04-12 |
2014-06-10 |
Rutgers, The State University Of New Jersey |
Biodegradable polyanhydrides with natural bioactive molecules
|
|
PL2172471T3
(pl)
|
2007-04-18 |
2013-08-30 |
Teva Pharma |
Sposób otrzymywania produktów pośrednich inhibitorów reduktazy HMG-CoA
|
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
|
US10183001B1
(en)
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
|
US9421266B2
(en)
|
2007-05-22 |
2016-08-23 |
Pisgah Laboratories, Inc. |
Safety of pseudoephedrine drug products
|
|
US7947733B2
(en)
|
2007-07-31 |
2011-05-24 |
Limerick Biopharma |
Phosphorylated pyrone analogs and methods
|
|
MY157192A
(en)
|
2007-08-03 |
2016-05-13 |
Richter Gedeon Nyrt |
Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
|
|
US20090041800A1
(en)
|
2007-08-06 |
2009-02-12 |
Synosia Therapeutics, Inc. |
Methods for Treating Dependence
|
|
FR2919861A1
(fr)
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
|
AU2016208412A1
(en)
|
2007-08-06 |
2016-08-18 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
EP2183227B1
(fr)
|
2007-08-07 |
2014-09-24 |
Prosarix Limited |
Dérivés de 1,2,4-triazole autant que modulateurs sérotoniques
|
|
US8067028B2
(en)
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
WO2009043174A1
(fr)
|
2007-10-05 |
2009-04-09 |
Interface Biologics Inc. |
Polymères réticulés oligofluorés et leurs utilisations
|
|
WO2009049215A1
(fr)
|
2007-10-10 |
2009-04-16 |
Wake Forest University Health Sciences |
Procédés pour réduire les effets du manque de sommeil
|
|
WO2009055001A2
(fr)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Procédés pour le traitement du vieillissement et procédés de dépistage des agents contribuant à celui-ci
|
|
WO2009061436A1
(fr)
|
2007-11-06 |
2009-05-14 |
University Of Florida Research Foundation |
Composé pour activer les récepteurs 5-ht2c en combinaison avec un composé amphétamine
|
|
DE102007063210A1
(de)
|
2007-12-20 |
2009-06-25 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Arzneimittel zur Behandlung von Phantomphänomenen
|
|
WO2009079765A1
(fr)
|
2007-12-21 |
2009-07-02 |
Cascade Therapeutics Inc. |
Composés dont l'activité est dirigée contre le récepteur 5-ht2c
|
|
WO2009089234A2
(fr)
|
2008-01-07 |
2009-07-16 |
Auspex Pharmaceuticals |
Dibenzhydrylpipérazines substituées
|
|
CA2905541C
(fr)
|
2008-01-09 |
2020-02-11 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques renfermant un antiemetique et un analgesique opioide
|
|
US8137690B2
(en)
|
2008-01-17 |
2012-03-20 |
Health Innovations, Llc |
Taste titration therapies
|
|
US8329663B2
(en)
|
2008-01-31 |
2012-12-11 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
WO2009097596A1
(fr)
|
2008-01-31 |
2009-08-06 |
Paul Griffin |
Compositions et méthodes pour le traitement d'infections chroniques
|
|
US8906847B2
(en)
|
2008-02-01 |
2014-12-09 |
Ascendis Pharma A/S |
Prodrug comprising a drug linker conjugate
|
|
WO2009109428A2
(fr)
|
2008-02-01 |
2009-09-11 |
Alpha-O Peptides Ag |
Nanoparticules peptidiques à auto-assemblage utiles comme vaccins
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US20090318527A1
(en)
|
2008-02-11 |
2009-12-24 |
Howard Sard |
Indole compounds and methods of use thereof
|
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
|
EA201001521A1
(ru)
|
2008-03-26 |
2011-04-29 |
Лонца Лтд. |
Способ синтеза этинилциклопропана
|
|
US20170276676A1
(en)
|
2008-03-27 |
2017-09-28 |
Gus J. Slotman |
System for assessing drug efficacy and response of a patient to therapy
|
|
WO2009118763A1
(fr)
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Compositions pharmaceutiques multicouches et procédés correspondants
|
|
US20090252786A1
(en)
|
2008-03-31 |
2009-10-08 |
Christoph Hanz |
Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
|
|
EP2106799A1
(fr)
|
2008-03-31 |
2009-10-07 |
OWEN Holding LTD |
Utilisation d'un sérum sanguin biologiquement actif pour le traitement d'un trouble caractérisé par une fonction réduite d'un récepteur GABA
|
|
FR2930147B1
(fr)
|
2008-04-18 |
2013-02-08 |
Flamel Tech Sa |
Forme orale solide dotee d'un double profil de liberation
|
|
CN102014625A
(zh)
|
2008-04-28 |
2011-04-13 |
佐吉尼克斯股份有限公司 |
用于治疗偏头痛的新制剂
|
|
WO2009149252A1
(fr)
|
2008-06-04 |
2009-12-10 |
Cornell University |
Vaccins pour la prévention et le traitement d’une dépendance
|
|
US10388179B2
(en)
|
2008-06-18 |
2019-08-20 |
Accenture Global Solutions Limited |
Analytics platform
|
|
CN105456181A
(zh)
|
2008-06-19 |
2016-04-06 |
Lts罗曼治疗方法有限公司 |
阳离子活性剂透皮输运组合物
|
|
EP2313037A1
(fr)
|
2008-06-30 |
2011-04-27 |
Oron Zachar |
Application dermique de vasoconstricteurs
|
|
US9642819B2
(en)
|
2008-07-10 |
2017-05-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical |
Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
|
|
US8617607B2
(en)
|
2008-07-10 |
2013-12-31 |
Tyrx, Inc. |
Sustained release formulations of psychoactive drugs
|
|
CA2732131A1
(fr)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions et procedes de traitement de troubles psychiatriques
|
|
FR2935611B1
(fr)
|
2008-09-10 |
2010-10-15 |
Commissariat Energie Atomique |
Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes
|
|
FR2936710B1
(fr)
|
2008-10-07 |
2011-01-07 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
CA3037010A1
(fr)
|
2009-01-20 |
2010-07-29 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Cente |
Acide sorbique et benzoique et derives de celui-ci pour ameliorer l'activite d'un produit neuropharmaceutique
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2010124089A2
(fr)
|
2009-04-22 |
2010-10-28 |
Synosia Therapeutics, Inc. |
Procédés pour traiter une dépendance
|
|
WO2010123577A2
(fr)
|
2009-04-24 |
2010-10-28 |
Galenea Corp. |
Compositions et procédés pour évaluer des déficits cognitifs
|
|
BRPI1012038A2
(pt)
|
2009-05-26 |
2017-06-27 |
Shire Llc |
métodos de aumentar os efeitos dos inibidores da reabsorção de serotonina seletivos em mamíferos
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US20110306596A1
(en)
|
2009-07-27 |
2011-12-15 |
Auspex Pharmaceuticals, Inc. |
Benzazepine inhibitors of gamma-secretase
|
|
WO2011020030A2
(fr)
|
2009-08-13 |
2011-02-17 |
The General Hospital Corporation |
Procédés et compositions pour empêcher la dépendance
|
|
US20110038915A1
(en)
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
US20120171239A1
(en)
|
2009-09-03 |
2012-07-05 |
Mizel Steven B |
Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
|
|
FR2954167A1
(fr)
|
2009-09-04 |
2011-06-24 |
Centre Nat Rech Scient |
Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
JP5743287B2
(ja)
|
2009-10-16 |
2015-07-01 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
ビス−（アルファ−アミノ−ジオール−ジエステル）を含有するポリエステルアミドを含むコーティング
|
|
EP2490677A2
(fr)
|
2009-10-19 |
2012-08-29 |
Intec Pharma Ltd. |
Nouvelles formes pharmaceutiques à rétention gastrique de médicaments peu solubles
|
|
US8900603B2
(en)
|
2009-12-18 |
2014-12-02 |
Interface Biologics, Inc. |
Local delivery of drugs from self assembled coatings
|
|
LT2531200T
(lt)
|
2010-02-06 |
2017-09-25 |
Grünenthal GmbH |
Kristalizacijos būdas ir bioprieinamumas
|
|
US20110217289A1
(en)
|
2010-03-05 |
2011-09-08 |
Basf Se |
Melt-Coated Dosage Forms
|
|
CA2829180C
(fr)
|
2010-03-05 |
2019-01-15 |
Newagriculture, Inc. |
Complexes de matiere de proteine en feuille lipidosoluble
|
|
CN102892429B
(zh)
|
2010-03-17 |
2016-08-31 |
康奈尔大学 |
基于被破坏的腺病毒的抗滥用药物疫苗
|
|
WO2011138142A1
(fr)
|
2010-05-07 |
2011-11-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Compositions et utilisation de sulfasalazine
|
|
US20110300083A1
(en)
|
2010-05-10 |
2011-12-08 |
Segetis, Inc. |
Personal care formulations containing alkyl ketal esters and methods of manufacture
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US20120108510A1
(en)
|
2010-05-20 |
2012-05-03 |
Emory University |
Methods of improving behavioral therapies
|
|
JP2012020991A
(ja)
|
2010-06-16 |
2012-02-02 |
Takasago Internatl Corp |
経皮吸収促進剤、及びこれを含有する皮膚外用製剤
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
WO2012012764A1
(fr)
|
2010-07-23 |
2012-01-26 |
Demerx, Inc. |
Compositions de noribogaïne
|
|
US8900591B2
(en)
|
2010-08-20 |
2014-12-02 |
Heptares Therapeutics Limited |
Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
|
|
CA2812063A1
(fr)
|
2010-08-30 |
2012-06-07 |
President And Fellows Of Harvard College |
Liberation controlee par cisaillement pour lesions stenosees et traitements thrombolytiques
|
|
WO2012031125A2
(fr)
|
2010-09-01 |
2012-03-08 |
The General Hospital Corporation |
Inversion des effets d'une anesthésie générale par administration de phénidate de méthyle, d'amphétamine, de modafinil, d'amantadine, et/ou de caféine
|
|
US20120129834A1
(en)
|
2010-09-17 |
2012-05-24 |
Buck Institute For Research On Aging |
Serotonin receptor antagonists for use in the treatment of huntington's disease
|
|
WO2012039660A1
(fr)
|
2010-09-20 |
2012-03-29 |
A. Carlsson Research Ab |
Composés de phénylpipéridine pour le traitement de troubles neurologiques et psychiatriques
|
|
WO2012045118A1
(fr)
|
2010-10-07 |
2012-04-12 |
Eaglepharma Pty Ltd |
Polythérapie destinée au traitement de la dépression et d'autres maladies non infectieuses
|
|
WO2012054815A1
(fr)
|
2010-10-22 |
2012-04-26 |
Duke University |
Formulations à libération prolongée de 5-hydroxytryptophane en tant que complément à des thérapies pro-sérotonergiques
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
PT2640370T
(pt)
|
2010-11-15 |
2018-06-15 |
Neuroderm Ltd |
Composições para entrega transdérmica de agentes ativos
|
|
CN103354902B
(zh)
|
2010-12-06 |
2016-03-02 |
特拉维夫大学拉玛特有限公司 |
药物检测方法和试剂盒
|
|
CA2822738C
(fr)
|
2010-12-22 |
2021-06-08 |
Exonoid Medical Devices Ltd. |
Procede et systeme d'administration de medicament
|
|
EP2481740B1
(fr)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Procédés et compositions pour préparer de la noribogaïne à partir de voacangine
|
|
FR2971423B1
(fr)
|
2011-02-15 |
2014-01-10 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
US20140017803A1
(en)
|
2011-03-28 |
2014-01-16 |
Flir Systems, Inc. |
Detection of analytes including drugs
|
|
US8742096B2
(en)
|
2011-03-28 |
2014-06-03 |
Demerx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
AR085840A1
(es)
|
2011-04-05 |
2013-10-30 |
Otsuka Pharma Co Ltd |
Medicamento que contiene un compuesto que es 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi]-1h-quinolin-2-ona
|
|
US20120282255A1
(en)
|
2011-04-07 |
2012-11-08 |
Greg Plucinski |
Methods and compositions for the treatment of alcoholism and alcohol dependence
|
|
KR20120128440A
(ko)
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
US9089563B2
(en)
|
2011-05-19 |
2015-07-28 |
Gilrose Pharmaceuticals, Llc |
Method of treating apraxia of speech in children
|
|
MX2013015373A
(es)
|
2011-06-23 |
2014-02-11 |
Map Pharmaceuticals Inc |
Nuevos analogos de fluoroergolina.
|
|
CN103857397B
(zh)
|
2011-09-15 |
2016-08-17 |
德莫科斯公司 |
降伊波加因碱盐非溶剂化物
|
|
US20130116215A1
(en)
|
2011-10-28 |
2013-05-09 |
Mireia Coma |
Combination therapies for treating neurological disorders
|
|
WO2013068949A1
(fr)
|
2011-11-07 |
2013-05-16 |
Novartis Ag |
Molécule porteuse comprenant un antigène spr0096 et un antigène spr2021
|
|
FR2983409B1
(fr)
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
|
CA3122767C
(fr)
|
2011-12-08 |
2023-03-28 |
Demerx, Inc. |
Synthese totale stereoselective de noribogaine
|
|
EP2788356A4
(fr)
|
2011-12-09 |
2015-10-21 |
Demerx Inc |
Esters de sulfate de noribogaïne
|
|
WO2013085922A1
(fr)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Esters phosphoriques de noribogaïne
|
|
EP2607352A1
(fr)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-diketoamides pour le traitement des troubles psychiatriques
|
|
EP2610245A1
(fr)
|
2011-12-28 |
2013-07-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-sulfonamides pour le traitement des troubles psychiatriques
|
|
WO2013112163A1
(fr)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Dérivés d'isoquinuclidène fusionnés à de l'indole et du benzofurane et procédés de préparation de ceux-ci
|
|
WO2013112757A1
(fr)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Dérivés d'isoquinuclidène réunis par fusion à de l'indole et du benzofurane et leurs procédés de préparation
|
|
US8877921B2
(en)
|
2012-01-25 |
2014-11-04 |
Demerx, Inc. |
Synthetic voacangine
|
|
EP2649989B1
(fr)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Procédé de préparation d'une dispersion solide, dispersion solide ainsi obtenue et son utilisation
|
|
US20130295170A1
(en)
|
2012-05-03 |
2013-11-07 |
Kydes Pharmaceuticals Llc |
Compositions for control of drug abuse
|
|
JP2013233437A
(ja)
|
2012-05-07 |
2013-11-21 |
Otsuka Pharmaceut Co Ltd |
脳波振動のシグネチャ
|
|
EP3785720A1
(fr)
|
2012-05-09 |
2021-03-03 |
Cantex Pharmaceuticals, Inc. |
Traitement de la myélosuppression
|
|
US20150196533A1
(en)
|
2012-07-02 |
2015-07-16 |
The General Hospital Corporation |
Method for concurrent treatment of pain and depression
|
|
US8784835B2
(en)
|
2012-07-02 |
2014-07-22 |
Trent Austin |
Method for producing muscimol and/or reducing ibotenic acid from amanita tissue
|
|
EP2690102A1
(fr)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Aza-amides bicycliques pour le traitement de troubles psychiatriques
|
|
WO2014028796A2
(fr)
|
2012-08-17 |
2014-02-20 |
Smartek International Llc |
Préparation de liposomes desséchés utilisable dans des systèmes d'administration compressibles
|
|
CA2882870C
(fr)
|
2012-08-24 |
2020-12-15 |
Integurx Therapeutics, Llc |
Compositions chimiques et procedes pour ameliorer l'administration transdermique d'agents therapeutiques
|
|
US20140066881A1
(en)
|
2012-08-31 |
2014-03-06 |
Zoll Medical Corporation |
Cardiac resuscitation methods and kits
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
US20150231300A1
(en)
|
2012-10-28 |
2015-08-20 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
|
WO2014078857A1
(fr)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Dérivés d'ergoline en tant que modulateurs d'un récepteur de la dopamine
|
|
WO2014093277A1
(fr)
|
2012-12-11 |
2014-06-19 |
The Mclean Hospital Corporation |
Traitement de xénon et/ou d'argon comme complément de psychothérapie pour troubles psychiatriques
|
|
US9783535B2
(en)
|
2012-12-20 |
2017-10-10 |
Demerx, Inc. |
Substituted noribogaine
|
|
WO2014117089A1
(fr)
|
2013-01-25 |
2014-07-31 |
Case Western Reserve University |
Compositions et méthodes de traitement de troubles envahissants du développement
|
|
WO2014130581A1
(fr)
|
2013-02-20 |
2014-08-28 |
Questcor Pharmaceuticals, Inc. |
Acth utile dans le traitement de la migraine et des céphalées
|
|
CN105142611B
(zh)
|
2013-03-10 |
2019-06-04 |
佩丽泰克医药有限公司 |
外用组合物及治疗局部病症的方法
|
|
WO2014153099A2
(fr)
|
2013-03-14 |
2014-09-25 |
Pulmonary Analytics |
Méthode d'utilisation de l'air expiré pour déterminer la présence de drogue
|
|
WO2014146082A1
(fr)
|
2013-03-15 |
2014-09-18 |
Bhl Patent Holdings Llc |
Substances et méthodes permettant de traiter des neuropathies et les troubles associés y compris ceux impliquant un nerf clé
|
|
WO2014142938A1
(fr)
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Formulation pharmaceutique contenant un glycosaminoglycane
|
|
EA032064B1
(ru)
|
2013-03-15 |
2019-04-30 |
Мелиор Фармасьютикалз Ii, Ллс |
Способ лечения леводопа-индуцированной дискинезии с применением сиднокарба
|
|
CA2942638A1
(fr)
|
2013-03-15 |
2014-09-18 |
Demerx, Inc. |
Procede pour le traitement avec la noribogaine de l'addiction de patients sous methadone
|
|
WO2014176556A1
(fr)
|
2013-04-26 |
2014-10-30 |
Express Diagnostics International, Inc. |
Système d'analyse portatif pour détecter la présence de substances ou de composés sélectionnés dans des environnement non contrôlés
|
|
WO2014186623A2
(fr)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Méthodes et compositions pour le traitement de la maladie de chagas
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
CA2817728A1
(fr)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Formulation a liberation immediate de prevention des abus
|
|
EP3003031A1
(fr)
|
2013-06-04 |
2016-04-13 |
Vyome Biosciences Pvt Ltd |
Particules enrobées et compositions les comprenant
|
|
US20140364367A1
(en)
|
2013-06-08 |
2014-12-11 |
Sedogen, Llc |
Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener
|
|
EP2818177A1
(fr)
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mécanisme et cibles de médicaments pour la réduction de l'oedème cellulaire (neuroprotection) et l'excitabilité cytoplasmique dans les astrocytes en états normaux et pathologiques
|
|
WO2015003059A1
(fr)
|
2013-07-03 |
2015-01-08 |
Acura Pharmaceuticals, Inc. |
Procédés et compositions permettant d'empêcher l'utilisation abusive
|
|
US20150011630A1
(en)
|
2013-07-08 |
2015-01-08 |
Auspex Pharmaceuticals, Inc. |
Dihydroxyphenyl neurotransmitter compounds, compositions and methods
|
|
US10624862B2
(en)
|
2013-07-12 |
2020-04-21 |
Grünenthal GmbH |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
US10098893B2
(en)
|
2013-10-03 |
2018-10-16 |
Northwestern University |
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
|
|
US9420970B2
(en)
|
2013-10-22 |
2016-08-23 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on mobile device usage
|
|
US9474481B2
(en)
|
2013-10-22 |
2016-10-25 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on electronic device usage
|
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
|
MX2016005477A
(es)
|
2013-10-31 |
2016-08-03 |
Cima Labs Inc |
Formas de dosificacion disuasivas del abuso.
|
|
WO2015066344A1
(fr)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
Agonistes du récepteur 5-ht2c et compositions et procédés d'utilisation
|
|
TW201605856A
(zh)
|
2013-11-01 |
2016-02-16 |
艾尼納製藥公司 |
５－ＨＴｃ受體促效劑
|
|
CN103535561A
(zh)
|
2013-11-05 |
2014-01-29 |
杨剑 |
饲养大猪用的牧草饲料
|
|
CN103549133A
(zh)
|
2013-11-05 |
2014-02-05 |
杨剑 |
有机猪牧草饲料
|
|
CN103751943B
(zh)
|
2014-01-13 |
2020-10-13 |
湖北及安盾消防科技有限公司 |
一种含有含氮类有机化合物的灭火组合物
|
|
CN103773056B
(zh)
|
2014-01-24 |
2015-11-18 |
山东大学 |
高脆性透明类岩石材料试件制备方法
|
|
WO2015112168A2
(fr)
|
2014-01-24 |
2015-07-30 |
Demerx, Inc. |
Compositions comprenant de la noribogaïne et un excipient pour faciliter le transport à travers la barrière hémato-encéphalique
|
|
EP3113771A4
(fr)
|
2014-03-03 |
2017-10-25 |
DemeRx, Inc. |
Utilisations therapeutiques de l'ibogaïne et composes associes
|
|
US20150258114A1
(en)
|
2014-03-13 |
2015-09-17 |
Demerx, Inc. |
Methods for acute and long-term treatment of substance abuse using ibogaine
|
|
US9878138B2
(en)
|
2014-06-03 |
2018-01-30 |
Pop Test Abuse Deterrent Technology Llc |
Drug device configured for wireless communication
|
|
JP6940916B2
(ja)
|
2014-07-30 |
2021-09-29 |
ゲノム プロテクション，インコーポレイテッド |
フラジェリン組成物および使用
|
|
US10231651B2
(en)
|
2014-09-25 |
2019-03-19 |
Bae Systems Information And Electronic Systems Integration Inc. |
Gait authentication system and method thereof
|
|
US10058253B2
(en)
|
2014-11-11 |
2018-08-28 |
Zenmark, Llc |
System, method, and article for heart rate variability monitoring
|
|
WO2016145193A1
(fr)
|
2015-03-10 |
2016-09-15 |
Eleusis Benefit Corporation, Pbc |
Lsd pour le traitement de la maladie d'alzheimer
|
|
TW201642837A
(zh)
|
2015-03-24 |
2016-12-16 |
Kyowa Hakko Kirin Co Ltd |
含有核酸之脂質奈米粒子
|
|
US10254298B1
(en)
|
2015-03-25 |
2019-04-09 |
National Technology & Engineering Solutions Of Sandia, Llc |
Detection of metabolites for controlled substances
|
|
EP3277271B1
(fr)
*
|
2015-03-31 |
2021-07-21 |
Turtle Bear Holdings, LLC |
Activité antivirale de champignons médicinaux et leur ingrédients actifs
|
|
HUE047169T2
(hu)
|
2015-04-27 |
2020-04-28 |
Arena Pharm Inc |
5-HT2C receptor agonisták és készítmények és felhasználási eljárások
|
|
WO2016178053A1
(fr)
|
2015-05-01 |
2016-11-10 |
Lozinsky Evgenia |
Compositions pour le traitement de l'epistaxis
|
|
WO2016187277A1
(fr)
|
2015-05-19 |
2016-11-24 |
Joseph Robert Knight |
Procédé d'isolation d'alcaloïdes et d'acides aminés, et compositions contenant des alcaloïdes et des acides aminés isolés
|
|
US20180147142A1
(en)
|
2015-05-19 |
2018-05-31 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US9737759B2
(en)
|
2015-07-17 |
2017-08-22 |
Genesant Technologies, Inc. |
Automatic application-based exercise tracking system and method
|
|
MA42527A
(fr)
|
2015-07-31 |
2021-04-07 |
Arena Pharm Inc |
Agonistes de récepteur 5-ht2c et compositions et procédés d'utilisation
|
|
US9614734B1
(en)
|
2015-09-10 |
2017-04-04 |
Pearson Education, Inc. |
Mobile device session analyzer
|
|
US20180021326A1
(en)
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
EP3500570B1
(fr)
|
2016-08-19 |
2022-10-05 |
Arena Pharmaceuticals, Inc. |
Agonistes des récepteurs 5-ht2c, compositions et méthodes d'utilisation
|
|
US10596378B2
(en)
|
2016-10-18 |
2020-03-24 |
Joseph Rustick |
Method for treatment of depression using synaptic pathway training
|
|
US20180195455A1
(en)
|
2017-01-12 |
2018-07-12 |
GM Global Technology Operations LLC |
Engine combustion phasing control during transient state
|
|
NL2018190B1
(en)
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
CA3051914A1
(fr)
|
2017-02-02 |
2018-08-09 |
Mcmaster University |
Bicarbonate a titre de potentialisateur d'agents antimicrobiens
|
|
WO2018145219A1
(fr)
|
2017-02-09 |
2018-08-16 |
Serani Mostazal Jorge |
Composition pharmaceutique pour la prévention et le traitement des addictions à travers un contre-conditionnement aversif
|
|
CN110740728A
(zh)
|
2017-02-09 |
2020-01-31 |
卡马技术有限责任公司 |
包含裸头草碱衍生物的组合物和方法
|
|
CN108619214A
(zh)
|
2017-03-15 |
2018-10-09 |
王慎君 |
一种治疗肿瘤的药物
|
|
BR112019020554A2
(pt)
|
2017-03-30 |
2020-04-28 |
Ojai Energetics Pbc |
métodos e composições para melhorar as condições de saúde
|
|
CA3059072A1
(fr)
|
2017-04-07 |
2018-10-11 |
ACEA Therapeutics, Inc. |
Sels pharmaceutiques, formes physiques, compositions d'inhibiteurs kinases de pyrrolopyrimidine, et leurs procedes de preparation
|
|
WO2018195455A1
(fr)
|
2017-04-20 |
2018-10-25 |
Eleusis Benefit Corporation, Pbc |
Évaluation et traitement de sujets réactifs aux agents psychédéliques
|
|
US20180343812A1
(en)
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
US20190246591A1
(en)
|
2017-05-31 |
2019-08-15 |
Insectergy, Llc |
Insect and cannabis production systems and methods
|
|
EP3629899A4
(fr)
|
2017-06-02 |
2021-04-21 |
Northwestern University |
Réseaux microfluidiques minces, souples et installés sur la peau pour la détection et l'analyse de cibles d'intérêt dans la sueur
|
|
CN107252080A
(zh)
|
2017-07-12 |
2017-10-17 |
沈建国 |
一种麻菇酱油的配方
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
CA3079560A1
(fr)
|
2017-10-19 |
2019-04-25 |
Eleusis Benefit Corporation, Pbc |
Procedes et systemes d'amelioration de la securite des pharmacotherapies psychedeliques
|
|
US11723894B2
(en)
|
2017-10-26 |
2023-08-15 |
Terran Biosciences, Inc. |
Combination product for the treatment of neurological and/or psychiatric disorders
|
|
WO2019099745A1
(fr)
|
2017-11-16 |
2019-05-23 |
CaaMTech, LLC |
Compositions comprenant un dérivé de psilocybine et un cannabinoïde
|
|
US10703325B2
(en)
|
2017-11-27 |
2020-07-07 |
Autoliv Asp, Inc. |
Multi-chambered side airbag assemblies
|
|
EP3720506A4
(fr)
|
2017-12-04 |
2021-09-29 |
Lecouteur, David |
Compositions et méthodes pour moduler les fenestrations de cellules endothéliales hépatiques
|
|
FI128750B
(en)
|
2017-12-21 |
2020-11-30 |
Helsingin Yliopisto |
Methods for determining the therapeutic effect of fast-acting antidepressants and related individual antidepressant therapy
|
|
WO2019144140A1
(fr)
|
2018-01-22 |
2019-07-25 |
CyPhi LLC |
Formulation bio-mimétique
|
|
WO2019161050A1
(fr)
|
2018-02-18 |
2019-08-22 |
Akili Interactive Labs, Inc. |
Plateforme cognitive comprenant des éléments informatisés couplés à une thérapie contre les troubles de l'humeur
|
|
BR112020018306A2
(pt)
|
2018-03-08 |
2020-12-22 |
New Atlas Biotechnologies Llc. |
Processos para a produção de triptaminas
|
|
FI129102B
(en)
|
2018-03-19 |
2021-07-15 |
Teknologian Tutkimuskeskus Vtt Oy |
Heterological production of psilosybin
|
|
AU2019262197A1
(en)
|
2018-05-04 |
2020-11-26 |
Perception Neuroscience, Inc. |
Methods of treating substance abuse
|
|
US12083116B2
(en)
|
2018-06-21 |
2024-09-10 |
Robert John Petcavich |
Method of inducing dendritic and synaptic genesis in neurodegenerative chronic diseases
|
|
EP3829640A4
(fr)
|
2018-08-01 |
2022-05-25 |
McMaster University |
Méthodes d'inhibition de la croissance microbienne
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
WO2020053196A1
(fr)
|
2018-09-10 |
2020-03-19 |
Universität Basel |
Procédé pour l'alkylation biocatalytique d'un substrat
|
|
US11534571B2
(en)
|
2019-01-04 |
2022-12-27 |
Apollo Neuroscience, Inc. |
Systems and methods of facilitating sleep state entry with transcutaneous vibration
|
|
EP3917537A4
(fr)
|
2019-01-30 |
2022-09-07 |
Diamond Therapeutics Inc. |
Compositions et méthodes comprenant un agoniste de récepteur 5ht destinées au traitement de troubles psychologiques, cognitifs, comportementaux et/ou d'humeur
|
|
WO2020212948A1
(fr)
|
2019-04-17 |
2020-10-22 |
Compass Pathfinder Limited |
Procédés pour traiter les troubles neurocognitifs, la douleur chronique, et pour réduire l'inflammation
|
|
US11766445B2
(en)
|
2019-07-18 |
2023-09-26 |
Concept Matrix Solutions |
Oral soft gel capsule containing psychedelic compound
|
|
EP4009026B1
(fr)
|
2020-12-02 |
2024-09-18 |
Volvo Truck Corporation |
Un système de véhicule actionné par air et un procédé de détection de fuites dans un système de véhicule actionné par air
|
|
US20240197758A1
(en)
|
2021-03-30 |
2024-06-20 |
Compass Pathfinder Limited |
Psilocybin compositions, methods of making and methods of using the same
|